Events Partner Content 3rd Microbiome Movement – Maternal & Infant Health Summit Treatment creation for maternal and infant microbiome
Partner Content Partner Content Personal Highlights – Microbiome Movement – Maternal & I... Discovering The Maternal-Infant Microbiome
News Lexicon's type 1 diabetes drug voted down by FDA adcomm It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
